Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

Bibliographic Details
Main Authors: Betancor, Gilberto, Garriga, César, Puertas, Maria C, Nevot, María, Anta, Lourdes, Blanco, José L, Pérez-Elías, M Jesús, de Mendoza, Carmen, Martínez, Miguel A, Martinez-Picado, Javier, Menéndez-Arias, Luis
Format: Online
Language:English
Published: BioMed Central 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468358/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468358/

Similar Items